We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Women Advised to Get Yearly Mammograms Starting at Age 40

By HospiMedica International staff writers
Posted on 08 Jan 2015
A study of breast tumors identified with screening mammography revealed that a strong family history and dense breast tissue were typically absent in women between the ages of 40 and 49 diagnosed with breast cancer. More...


The study’s findings were presented at the annual meeting of the Radiological Society of North America (RSNA), held November 30 to December 4, 2014, in Chicago (IL, USA). “Screening recommendations for this age group continue to be debated,” said Bonnie N. Joe, MD, PhD, associate professor in residence and chief of women’s imaging at the University of California, San Francisco (UCSF; USA). “Recent publications have suggested risk-based screening based on family history and breast density. However, our study shows that this approach would miss a significant percentage of invasive cancers and could potentially be dangerous.”

The retrospective study, conducted at UCSF, included 136 women between the ages of 40 and 49 with breast cancer identified by screening mammography between 1997 and 2012. Symptomatic patients undergoing diagnostic mammography and those with a personal history of breast cancer were excluded from the study. Patient family history, breast density, type of malignancy, lymph node status, and tumor receptor status were logged. “Notably, we found that almost 90% of the invasive cancers we would have missed using risk-based triage had positive receptor status, meaning they were very treatable and worth finding early,” Dr. Joe said.

Of the 136 breast cancer cases identified, 50% were diagnosed as invasive, and 50% were diagnosed as ductal carcinoma in situ (DCIS), an early noninvasive form of breast cancer, although 88% of DCIS cases were intermediate or high grade. A very strong family history was absent in 90% of patients, and extremely dense breast tissue was absent in 86%. Seventy-eight percent of patients had neither a strong family history nor extremely dense breasts, including 79% of the cases of invasive disease.

“Our results show that by exclusively using a risk-based approach to screening mammography, we could potentially miss more than 75% of breast cancers in women in their 40s, thereby eliminating most of the survival benefit from screening mammography that has been previously shown in randomized controlled trials,” Dr. Joe commented.

Dr. Joe advises advocates of risk-based screening to continue research to find more effective ways of risk-based triage. “Neither family history nor breast density in combination or alone are sufficient risk factors to safely triage patients in risk-based screening,” she explained.

Regular annual screening mammography has traditionally been recommended by organizations such as the American Cancer Society (ACS) and the American Medical Association (AMA) for all women beginning at age 40. In 2009, the United States Preventive Services Task Force (USPSTF) issued controversial new guidelines recommending screening with mammography every two years beginning at age 50. “Based on our current knowledge and evidence shown in previous trials, it is still safest to get annual mammograms starting at age 40 in order to maximize the survival benefit of screening mammography,” Dr. Joe concluded.

Related Links:

University of California, San Francisco



Gold Member
STI Test
Vivalytic Sexually Transmitted Infection (STI) Array
Biochip Array Technology
Evidence MultiSTAT Drugs of Abuse Urine Multiplex Panel
Monitor/Defibrillator
Zenix
POC Respiratory/Sore Throat Test
BIOFIRE SPOTFIRE (R/ST) Panel
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: Graphical Abstract (Aoibhin M. Sheedy et al., A replenishable peritoneal implant for localized delivery and peritoneal fluid sampling in ovarian cancer, Device (2026). DOI: 10.1016/j.device.2026.101050)

New Implant Provides Sustained Localized Therapy for Ovarian Cancer

Ovarian cancer is often diagnosed at advanced stages because symptoms such as bloating, pain, and pelvic pressure are nonspecific. Standard care relies on surgery and systemic therapy, yet tools for targeted... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.